Package 47335-625-30

{"route": ["ORAL"], "spl_id": "2cd273e4-313f-3562-e063-6394a90ac135", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["2594753", "2594759", "2594760", "2594762"], "spl_set_id": ["dd9f81e4-50da-4551-aed5-559d304df42e"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["SUN PHARMACEUTICAL INDUSTRIES, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 GRANULE in 1 PACKET (47335-625-11)", "package_ndc": "47335-625-11", "marketing_start_date": "20220228"}, {"sample": false, "description": "30 GRANULE in 1 CARTON (47335-625-30)", "package_ndc": "47335-625-30", "marketing_start_date": "20220228"}, {"sample": false, "description": "60 GRANULE in 1 CARTON (47335-625-60)", "package_ndc": "47335-625-60", "marketing_start_date": "20220228"}], "brand_name": "ASPRUZYO SPRINKLE", "product_id": "47335-625_2cd273e4-313f-3562-e063-6394a90ac135", "dosage_form": "GRANULE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "47335-625", "generic_name": "Ranolazine", "labeler_name": "SUN PHARMACEUTICAL INDUSTRIES, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ASPRUZYO SPRINKLE", "active_ingredients": [{"name": "RANOLAZINE", "strength": "1000 mg/1"}], "application_number": "NDA216018", "marketing_category": "NDA", "marketing_start_date": "20220228", "listing_expiration_date": "20261231"}